Baricitinib/Dupilumab/UpadacitinibVarious toxicities and lack of efficacy: 8 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71776-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：83 / 83

相关论文

共 50 条

[41] SorafenibVarious toxicities and lack of efficacy : 21 case reports
Reactions Weekly, 2023, 1971 (1) : 238 - 238
[42] AntineoplasticsVarious toxicities and lack of efficacy: 3 case reports
Reactions Weekly, 2025, 2049 (1) : 44 - 44
[43] AnticoagulantsVarious toxicities and lack of efficacy: 21 case reports
Reactions Weekly, 2023, 1960 (1) : 39 - 39
[44] DecitabineVarious toxicities and lack of efficacy: 30 case reports
Reactions Weekly, 2022, 1937 (1) : 189 - 189
[45] AntineoplasticsVarious toxicities and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1933 (1) : 66 - 66
[46] CabozantinibVarious toxicities and lack of efficacy: 11 case reports
Reactions Weekly, 2023, 1977 (1) : 86 - 86
[47] Azathioprine/dupilumab/prednisoloneHypereosinophilia and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1906 (1) : 92 - 92
[48] AntineoplasticsVarious toxicities and lack of efficacy: 11 case reports
Reactions Weekly, 2023, 1969 (1) : 45 - 46
[49] AntineoplasticsVarious toxicities and lack of efficacy: 4 case reports
Reactions Weekly, 2021, 1886 (1) : 64 - 64
[50] ImatinibVarious toxicities and lack of efficacy: 5 case reports
Reactions Weekly, 2023, 1972 (1) : 182 - 182

← 1 2 3 4 5 →